Cancer Cause and Prevention Research in Washington
Cancer Cause and Prevention Research (93.393) awarded $123 million to recipients in Washington in 84 grants from fiscal 2021 to 2025, 3.4% of the program's national total. Fred Hutchinson Cancer Center received the most, $75.6 million.
- Awarded in Washington$123 million
- Awards84
- Share of the program3.4%
- Rank among states9th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 51 | $26.9 million |
| FY 2022 | 52 | $28.5 million |
| FY 2023 | 42 | $23.0 million |
| FY 2024 | 41 | $23.0 million |
| FY 2025 | 33 | $21.2 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Nonprofits | 45 | $75.6 million |
| University of Washington | Colleges and universities | 23 | $32.0 million |
| Washington State University | Colleges and universities | 2 | $3.2 million |
| Seattle Institute for Biomedical and Clinical Research | Nonprofits | 2 | $2.9 million |
| Seattle Children's Hospital | Nonprofits | 3 | $2.6 million |
| Talus Bioscience Inc | Small businesses | 2 | $2.5 million |
| Northwest Indian College Foundation | Colleges and universities | 1 | $1.2 million |
| Cancer Targeted Technology LLC | Small businesses | 1 | $999,998 |
| Fred Hutchinson Cancer Research Center | Nonprofits | 3 | $668,140 |
| Spectragen Informatics, LLC | Small businesses | 1 | $550,206 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Washington?
$123 million from fiscal 2021 to 2025, across 84 awards. Washington ranks 9th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Washington?
The largest recipient is Fred Hutchinson Cancer Center, with $75.6 million in 45 awards. Next are University of Washington and Washington State University.
Can organizations in Washington apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant